News

GlaxoSmithKline Pharmaceuticals Limited was erstwhile incorporated as Glindia Limited in November, 1924. The Company s name was changed to Glaxo (India) Limited from Glindia Limited in year 1987 ...
The global IPV vaccines market is estimated to be valued at USD 199.9 Mn in 2025 and expected to reach at USD 358.5 Mn by 2032 With a CAGR of 8.7% during the forecast period (2025-2032). Coherent ...
Stocks of several companies, including Advani Hotels & Resorts (India), Bajaj Finance, GlaxoSmithKline Pharmaceuticals, Jupiter Wagons, etc, will go ex-date today, i.e, May 30 2025. Check the full ...
In June 2025, AstraZeneca announced a Phase III study to determine the efficacy and safety of durvalumab + tremelimumab ...
Mumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Chinmay Sharma, Executive Vice President - ...
A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety ...
Company News Published 05/28/2025, 07:00 AM GSK’s new antibiotic shows promise in Phase 3 trial View all comments (0) 0 GSK 0.96% LONDON - GlaxoSmithKline PLC (LSE/NYSE: GSK) ...
Takeda Pharmaceutical Company Limited engages in the research ... It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine ...